Phase 2 Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing to sign a consent form and follow the treatment and follow-up schedule
- People who have been diagnosed with prostate cancer confirmed by a tissue sample (biopsy or surgery)
- People who have not received any previous treatment for prostate cancer
- People whose cancer has been found in nearby lymph nodes after an extended lymph node removal surgery, meeting specific criteria defined in the trial protocol (confirm with trial site)
- People aged 18 or older
- People with a general health and activity level above a certain threshold, as measured by a standard medical scoring system (confirm with trial site)
- People who are able to understand the information given about the trial
Who may not be able to join:
- People whose prostate cancer has come back after a previous period of being cancer-free
- People whose cancer has already spread to distant parts of the body, such as distant lymph nodes, bones, or other organs
- People who have had previous radiation therapy in a way that would make the radiation treatments in this trial impossible to deliver safely
- People who have had another type of cancer in the past, unless they have been cancer-free for more than 5 years (an exception may apply for a common, low-risk type of skin cancer — confirm with trial site)
- People with serious or active health conditions that could make it unsafe or impractical to receive the radiation treatments used in this trial
- People who have a condition that prevents them from understanding trial information
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Gert De Meerleer, Prof. Dr., UZ Leuven
Phone: 00 32 16 34 76 00
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Clinical relapse-free survival (cRFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.